, Tracking Stock Market Picks
Enter Symbol:
Geron Corporation (GERN) [hlAlert]

down 42.42 %

Geron Corporation (GERN) upgraded to Buy with price target $10 by Needham

Posted on: Tuesday,  Dec 10, 2013  8:25 AM ET by Needham

Needham rated Buy Geron Corporation (NASDAQ: GERN) on 12/10/2013, when the stock price was $5.35. Since
then, Geron Corporation has lost 42.43% as of 01/25/2016's recent price of $3.08.
If you would have followed this Needham's recommendation on GERN, you would have lost 42.42% of your investment in 776 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2013 8:25 AM Buy
5.35 10.00
as of 12/13/2013
1 Week down  -10.84 %
1 Month down  -10.84 %
3 Months down  -10.84 %
1 YTD down  -10.84 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/28/2012 8:25 AM Hold
11/2/2009 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy